IHS Chemical Week

Regions :: Western Europe :: Netherlands

DSM’s Pharma Business Reports Weak Results in First Quarter

6:39 AM MDT | May 8, 2012 | Deepti Ramesh

DSM says that the performance of the company’s pharmaceutical business in the first quarter of 2012 remained weak, although first signs of improvement are visible. The pharmaceutical business reported a 7% rise in first-quarter sales, compared with the year-ago period, to €175 million ($227 million). The business reported an Ebit loss of €8 million in the first quarter compared with an Ebit loss of €10 million in the year-ago period. DSM’s pharma business comprises DSM Pharmaceutical Products and DSM Sinochem Pharmaceuticals, the former...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa